LIMN · Forms 3, 4, 5
Insider trades at Liminatus Pharma, Inc.
No open-market insider buys or sells at Liminatus Pharma, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Liminatus Pharma, Inc. (LIMN) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Liminatus Pharma, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Ewon Comfortech Co., Ltd. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Valetudo Therapeutics LLC | 10% owner | Other | 3,448,926 | Form 4 | |||
| Valetudo Therapeutics LLC | 10% owner | Other | 4,373,603 | Form 4 | |||
| Iris Acquisition Holdings LLC | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| II Philip Wayne Lemons | Director | Became an insider (Form 3) | Form 3 | ||||
| Richard JaiHwan Baek | Director | Became an insider (Form 3) | Form 3 | ||||
| KH Feelux Co., Ltd | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Valetudo Therapeutics LLC | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Eun Sook Lee | Director | Became an insider (Form 3) | Form 3 | ||||
| Ji Yeon Baek | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.